LFP analysis of mice with KA-induced epilepsy revealed that Sh2d5-KO mice treated with fludarabine presented significant increases in the frequency of SLEs and the duration of SLEs (Figure 6, N–P). The gene discussed is SH2D5; the disease is epilepsy.